Abstract
In living tissue, cells are constantly exposed to a wide variety of sources of oxidative stress under both physiologic and pathologic situations [1]. In most circumstances, the cell’s built-in defense mechanisms ensure that these stresses do not overwhelm the normal functioning of the cellular machinery [1]. In situations of acute or chronic stress or disease, however, these defense mechanisms may be overwhelmed or incapacitated. When this occurs, the cell may be destroyed, or its ability to properly function impaired, which in turn may lead to secondary disease processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49: 481–493.
Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/ reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115–1127.
Flaherty JT. Myocardial injury mediated by oxygen free radicals. Symposium on oxidants and antioxidants. Am J Med 1991; 91(C): 3C79S-3C85S.
Kaneko M, Singal PK, Dhalla NS. Alterations in heart sarcolemmal Ca2+-ATPase and Ca2+-binding activities due to oxygen free radicals. Basic Res Cardiol 1990; 85: 45–54.
Zaleska MM, Wilson DF. Lipid hydroperoxides inhibit reacylation of phospholipids in neuronal membranes. J Neurochem 1989; 52: 255–260.
Cochrane CG. Mechanisms of oxidant injury of cells. Mol Aspects Med 1991; 12: 137–147.
Meij JTA, Suzuki S, Panagia V, Dhalla NS. Oxidative stress modifies the activity of cardiac sarcolemmal phopholipase C. Biochim Biophys Acta 1994; 1199: 6–12.
Dai J, Meij JTA, Padua R, Panagia V. Depression of cardiac sarcolemmal phospholipase D activity by oxidant-induced thiol modification. Circ Res 1992; 71: 970–977.
Julien P, Downar E, Angel A. Lipoprotein composition and transport in the pig and dog cardiac lymphatic system. Circ Res 1981; 49: 248–254.
Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc Natl Acad Sci USA, 1984; 81: 3883–3887.
Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785–1792.
Noguchi N, Gotoh N, Niki E. Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim Biophys Acta 1993; 1168: 348–357.
Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987; 262: 3603–3608.
Noguchi N, Gotoh N, Niki E. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals. Biochim Biophys Acta 1994; 1213: 176–182.
Liu K, Massaeli H, Pierce GN. The action of oxidized low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 1993; 268: 4145–4151.
Shinitzky M. Membrane fluidity and cellular functions. In: Shinitzky M, editor. Physiology of Membrane Fluidity, Vol. 1. Boca Raton, FL: CRC Press, 1984; 1–51.
Williams S, Meij JTA, Panagia V. Membrane phospholipids and adrenergic receptor function. Mol Cell Biochem 1995; 149 /150: 217–221.
Asano M, Hidaka H. Alterations in pharmacological receptor activities of rabbit arteries by sulfhydryl reagents. Jpn J Pharmacol 1983; 33: 227–240.
Bast A, Haenen GRMM. Receptor function in free radical mediated pathologies. In: Claassen V, editor. Trends in Drug Research. The Netherlands: Elsevier BV, 1990: 273–286.
Haenen GRMM, Veerman M, Bast A. Reduction of β-adrenoceptor function by oxidative stress in the heart. Free Radie Biol Med 1990; 9: 279–288.
Kaneko M, Chapman DC, Ganguly PK, Beamish RE, Dhalla NS. Modification of cardiac adrenergic receptors by oxygen free radicals. Am J Physiol 1991; 260: H821–H826.
Hara H, Kato H, Araki T, Onodera H, Kogure K. Involvement of lipid peroxidation and inhibitory mechanisms on ischemic neuronal damage in gerbil hippocampus: Quantitative autoradiographic studies on second messenger and neurotransmitter systems. Neuroscience 1991; 42: 159–169.
Kagiya T, Rocha-Singh KJ, Honbo N, Karliner JS. α1 Adrenoceptor mediated signal transduction in neonatal rat ventricular myocytes: effects of prolonged hypoxia and reoxygenation. Cardiovasc Res 1991; 25: 609–616.
Loesberg C, Van der Steit G, Hooyman GJ, Hensen EJ, Nijkamp FP. Membrane fluidity of guinea pig lymphocytes and the dysfunction of the respiratory airway and lymphocyte beta adrenergic systems of the guinea pig. Life Sci 1989; 45: 1227–1235.
Evora PRB, Pearson PJ, Schaff HV. Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction. Ann Thorac Surg 1994; 57: 1550–1556.
Fu LX, Ilebekk A, Kirkeben KA, Aksnes G, Waagstein F, Bergh CH, et al. Oxygen free radical injury and Gs mediated signal transduction in the stunned porcine myocardium. Cardiovasc Res 1992; 26: 449–455.
Ben-Arie N, Gileadi C, Schramm M. Interaction of the ß-adrenergic receptor with Gs following delipidation. Specific lipid requirements for Gs activation and GTPase function. Eur J Biochem 1988; 176: 649–654.
Resink TJ, Tkachuk VA, Bernhardt J, Bühler FR. Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb 1992; 12: 278–285.
Thorin E, Hamilton CA, Dominiczak MH, Reid JL. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release. Arterioscler Thromb 1994; 14: 453–459.
Gopalakrishna R, Anderson WB. Susceptibility of protein kinase C to oxidative inactivation: loss of both phosphotransferase activity and phorbol diester binding. FEBS Lett 1987; 225: 233–237.
Liu K, Pierce GN. The effects of low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 1993; 268: 376–3775.
Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL. The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct 1980; 13: 67–81.
Kugiyama K, Henry PD. Transfer of lysophosphatidylcholine from oxidized LDL to endothelial cells impairs endothelium-dependent arterial relaxation. J Am Coll Cardiol 1990; 15: 12A.
Stoll LL, Spector AA. Lysophosphatidylcholine causes cGMP-dependent verapamil-sensitive Ca2+ influx in vascular smooth muscle cells. Am J Physiol 1993; 264: C885–C893.
Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun 1990; 168: 301–308.
Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, et al. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res 1992; 71: 1422–1428.
Ohgushi M, Kugiyama K, Fukunaga K, Murohara T, Sugiyama S, Miyamoto E, et al. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb 1993; 13: 1525–1532.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Czubryt, M.P., Panagia, V., Pierce, G.N. (1996). The roles of free radicals, peroxides and oxidized lipoproteins in second messenger system dysfunction. In: Karmazyn, M. (eds) Myocardial Ischemia: Mechanisms, Reperfusion, Protection. EXS, vol 76. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-8988-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8988-9_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9857-7
Online ISBN: 978-3-0348-8988-9
eBook Packages: Springer Book Archive